- 01ApoB counts particles; LDL cholesterol weighs their cargo
Every LDL, VLDL, IDL and Lp(a) particle carries exactly one apoB, so apoB is a head count of the particles that can enter artery walls. LDL cholesterol measures how much cholesterol those particles carry. When many particles are small and carry little cholesterol, LDL-C looks fine while apoB is high, and when the two disagree, heart risk follows apoB 3.
An apoB of 130 mg/dL or more is high under the US guideline, and anything over 100 mg/dL misses the European target for moderate risk 12. ApoB is a head count. Every particle that can carry cholesterol into an artery wall has exactly one apoB protein on its surface: LDL; VLDL and IDL, the triglyceride-rich particles the liver releases; and Lp(a), an inherited particle. So an apoB result is the number of those particles in your blood 3. More particles means more plaque risk, which builds with both the level and the years spent at it. The test itself is on the apoB marker page.
What counts as high
Two guidelines set the apoB lines most clinicians use. The 2018 AHA/ACC guideline (from the American Heart Association and American College of Cardiology) treats an apoB of 130 mg/dL or more as a risk-enhancing factor, a finding that tips a borderline treatment decision toward treating 2. The 2019 ESC/EAS guideline (from the European Society of Cardiology and European Atherosclerosis Society) sets apoB targets by overall risk: under 100 mg/dL for moderate risk, under 80 mg/dL for high risk and under 65 mg/dL for very high risk, such as after a heart attack 1. Your clinician places you in a risk group from your age, blood pressure, smoking, diabetes and family history. To convert, divide mg/dL by 100 to get g/L: 130 mg/dL is 1.30 g/L (see lab units explained).
Where an example apoB of 118 mg/dL fallsmg/dL
The bands below are treatment targets and one risk-enhancer cutoff, each tied to its source. The range printed on your report may differ: many labs use population ranges whose upper limit sits above these guideline targets, so a result can be inside the lab range and still above target (reference ranges explained).
| Band | Level | What it usually means | Usual next step |
|---|---|---|---|
| Meets very-high-risk target | Under 65 mg/dL (0.65 g/L) | The ESC/EAS level aimed for after a heart attack or stroke 1 | Nothing extra for apoB |
| Meets high-risk target | 65 to 79 mg/dL | Under the ESC/EAS high-risk target of 80; meets every target except the very-high-risk one 1 | Routine lipid checks |
| Meets moderate-risk target | 80 to 99 mg/dL | Under the ESC/EAS moderate-risk target of 100; above target at high risk 1 | Your overall risk decides |
| Above target | 100 to 129 mg/dL | Above every ESC/EAS target; common with high triglycerides or a high-saturated-fat diet 1 | Read with triglycerides, HDL and Lp(a); diet changes; a risk estimate |
| High | 130 mg/dL (1.30 g/L) and over | AHA/ACC risk-enhancing factor, roughly equal to LDL-C of 160 2 | Risk review with a clinician; ask about FH if LDL-C is 190 or more |
A [apoB] level ≥130 mg/dL corresponds to an LDL-C >160 mg/dL and constitutes a risk-enhancing factor.Grundy SM et al., 2018 AHA/ACC Guideline on the Management of Blood Cholesterol 2
When it is urgent
No guideline sets a critical apoB value, because a high apoB does its harm over years. The urgent situations are symptoms and one companion number.
Is the result accurate?
ApoB is one of the steadier lipid results. Check these before reading a single flag as your true level.
- Fasting: makes little difference. After a normal meal apoB barely moves, so a non-fasting sample is valid 5 (how to prepare for a blood test).
- Medicines: some progestins, anabolic steroids, retinoids, cyclosporine and some antipsychotics push apoB-carrying particles up. The rise can be large and usually eases when the drug changes, so ask your prescriber before stopping or switching anything 1.
- Pregnancy: lipids rise through pregnancy, so a result taken while pregnant is not your baseline 1.
- Lab-to-lab differences: apoB tests are standardized and precise 1, but reference ranges differ between labs, so compare repeat results from the same lab.
Confirm any single result above 130 mg/dL on a repeat sample from the same lab before deciding anything. After a change in diet or medicine, the ESC/EAS guideline rechecks lipids about 8 weeks later, with a window of 4 to 12 weeks 1. A trend across two or three results says more than any single one (why trends beat single readings).
Causes
A high apoB comes from one of three routes: the liver releases too many particles, particles leave the blood too slowly, or an inherited particle such as Lp(a) adds to the count 3. Primary causes are genetic; secondary causes are lifestyle, another condition or a medicine 1.
Common
- Saturated fat in the diet (lifestyle): saturated fat lowers the number of LDL receptors that clear particles from the blood. Clue: LDL-C is high along with apoB. Confirm with LDL cholesterol on the same panel 1.
- Insulin resistance, excess weight around the middle or type 2 diabetes (secondary): the liver overproduces VLDL particles. Clue: triglycerides high, HDL low, glucose creeping up. Confirm with triglycerides, HDL, fasting glucose, HbA1c and fasting insulin; see insulin resistance and metabolic syndrome 3.
- Polygenic high cholesterol (many genes each nudging it up; primary): slow clearance with no single cause. Clue: high apoB and LDL-C with a family pattern. Confirm with LDL-C and a family history; see high cholesterol 1.
Less common
- Underactive thyroid (secondary): low thyroid hormone cuts LDL receptor activity. Clue: tiredness, feeling cold, weight gain (fatigue, always cold). Confirm with TSH; see hypothyroidism 1.
- Nephrotic syndrome (a kidney condition where protein leaks into urine) or chronic kidney disease (secondary): the liver makes more lipoproteins. Clue: swelling, frothy urine. Confirm with albumin, creatinine, eGFR and urine protein 1.
- Medicines listed above (secondary). Clue: apoB rose after starting the drug. Confirm with a repeat apoB after a medicine review with the prescriber 1.
- High Lp(a) (primary): each Lp(a) particle carries one apoB, so a high Lp(a) adds inherited particles to the count. Confirm with a one-off Lp(a) test 3.
Must not miss
- Familial hypercholesterolemia (FH, primary): a single gene change slows LDL clearance from birth. It affects about 1 in 300 people 7, and many are never diagnosed. Clue: LDL-C of 190 mg/dL or more in an adult, which the AHA/ACC guideline treats as its own severe group, or a parent or sibling with heart disease before 55 (men) or 65 (women) 2. Confirm with LDL-C, family testing and genetic testing; see familial hypercholesterolemia. Each parent, brother, sister and child has a 1 in 2 chance of carrying it, so ask your clinician about checking their LDL-C. Red flag: chest pain on exertion with these numbers needs a same-day medical review; call 911 if chest pain comes on at rest or lasts more than a few minutes.
- Very high triglycerides alongside high apoB (secondary or primary): VLDL and remnant particles pile up. Clue: triglycerides of 500 mg/dL or more 2. Confirm with triglycerides. Red flag: severe upper abdominal pain needs same-day care for possible pancreatitis.
Symptoms
A high apoB causes no symptoms at any level, and most people find out from a blood test. Symptoms appear only when plaque has already narrowed an artery (chest pain on effort, breathlessness) or, in FH with very high levels, as fatty lumps on tendons such as the Achilles 1. If you have other symptoms, such as tiredness or headaches, raise them with your doctor as a separate question.
Read it with your other markers
In a UK Biobank analysis of about 390,000 adults, heart-attack risk tracked the apoB particle count, and once apoB was known, LDL-C and triglycerides added little 4. Our apoB vs LDL comparison sets the two side by side; new to the panel, start with how to read your lipid panel.
Do your apoB and LDL agree?
Enter both numbers to see whether your particle count and your cholesterol tell the same story. Nothing leaves your browser.
The markers that sort the causes
| Pattern | What it suggests | Read more |
|---|---|---|
| High apoB, triglycerides 175 mg/dL or more, low HDL | Liver overproducing VLDL; the insulin-resistance pattern 23 | High triglycerides, low HDL |
| High apoB, normal LDL-C | Many small, cholesterol-poor particles; risk follows apoB 34 | ApoB vs LDL |
| High apoB, LDL-C 190 mg/dL or more, or early heart disease in the family | Possible familial hypercholesterolemia 2 | Familial hypercholesterolemia |
| High apoB, high Lp(a) | Inherited particle load on top of the usual drivers 3 | High Lp(a) |
| High apoB, high TSH | Underactive thyroid slowing clearance; thyroid treatment comes first, then a retest 1 | Hypothyroidism |
| High apoB/apoA1 ratio | Many apoB particles relative to HDL's apoA1; read it alongside apoB itself | ApoB/apoA1 ratio |
CalculatorCholesterol ratio calculatorYour triglyceride to HDL ratio and non-HDL from a standard panel flag the small-particle pattern that hides behind a normal LDL.Work it out What usually happens next
How a high apoB is usually worked up
How to lower high apoB
To lower apoB without medicine, the biggest lever is swapping saturated fat for unsaturated fat; fiber, plant sterols and weight loss add smaller steps. Psyllium alone cuts apoB by about 5 mg/dL 6. Combined, these can help a borderline result, but they are rarely enough on their own for FH.
| Change | Effect measured in people | Evidence type | Source |
|---|---|---|---|
| Swap saturated fat (butter, fatty meat, coconut oil) for unsaturated fat (olive oil, nuts, fish) | LDL-C rises about 0.8 to 1.6 mg/dL for every 1% of daily calories from saturated fat; the swap reverses this | Meta-analyses of controlled feeding trials | 1 |
| Psyllium fiber | ApoB down about 5 mg/dL and LDL-C about 13 mg/dL on average | Meta-analysis of randomized trials | 6 |
| Foods fortified with plant sterols or stanols | LDL-C down about 7 to 10% | Meta-analyses of randomized trials | 1 |
| Weight loss, if overweight | LDL-C down about 8 mg/dL per 10 kg lost, with larger falls in triglycerides | Meta-analyses | 1 |
| Less alcohol and added sugar when triglycerides are high | Fewer VLDL particles; triglycerides fall most | Randomized trials and cohorts | 1 |
| Regular exercise | Mainly lowers triglycerides and raises HDL; small effect on LDL-C | Meta-analyses | 1 |
For food lists, see foods that lower cholesterol. Fish oil does little here. Omega-3 lowers triglycerides 1 but does not reliably lower apoB. No supplement has evidence for lowering apoB as strong as the evidence for the diet changes above; the heart health supplements guide rates each one.
Supplements people ask about for high apoB
Treatment: when medicine comes in
Whether you need medicine rests on your overall heart risk, not on apoB alone 2. When it is needed, a statin comes first: a moderate-intensity statin typically lowers LDL-C by 30 to 49% and a high-intensity statin by 50% or more 2. If targets are not met, ezetimibe (a pill that blocks cholesterol absorption) lowers LDL-C a further 20% or so, and a PCSK9 inhibitor (an injection that boosts LDL clearance) about 60% 1. Bempedoic acid is a newer pill option for people who cannot take statins 1. See statins and your labs.
Free, no accountRead your blood testHave the full report? Read every marker on it, with apoB beside LDL, triglycerides, HDL and Lp(a).Read my results
Citations
- Mach F, Baigent C, Catapano AL et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. European Heart Journal. 2020;41(1):111-188.
- Grundy SM, Stone NJ, Bailey AL et al. 2018 AHA/ACC Guideline on the Management of Blood Cholesterol. Circulation. 2019;139(25):e1082-e1143.
- Sniderman AD, Thanassoulis G, Glavinovic T et al. Apolipoprotein B particles and cardiovascular disease: a narrative review. JAMA Cardiology. 2019;4(12):1287-1295.
- Marston NA, Giugliano RP, Melloni GEM et al. Association of apolipoprotein B-containing lipoproteins and risk of myocardial infarction in individuals with and without atherosclerosis. JAMA Cardiology. 2022;7(3):250-256.
- Nordestgaard BG, Langsted A, Mora S et al. Fasting is not routinely required for determination of a lipid profile: EAS and EFLM joint consensus statement. European Heart Journal. 2016;37(25):1944-1958.
- Jovanovski E, Yashpal S, Komishon A et al. Effect of psyllium fiber on LDL cholesterol and alternative lipid targets, non-HDL cholesterol and apolipoprotein B: a systematic review and meta-analysis of randomized controlled trials. American Journal of Clinical Nutrition. 2018;108(5):922-932.
- Beheshti SO, Madsen CM, Varbo A, Nordestgaard BG. Worldwide prevalence of familial hypercholesterolemia: meta-analyses of 11 million subjects. Journal of the American College of Cardiology. 2020;75(20):2553-2566.
Educational context only, not medical advice or a diagnosis. Always discuss your results with a clinician.
